PDI (protein disulfide-isomerase) catalyses the formation of native disulfide bonds of secretory proteins in the endoplasmic reticulum. PDI consists of four thioredoxin-like domains, of which two contain redox-active catalytic sites (a and a ′ ), and two do not (b and b ′ ). The b ′ domain is primarily responsible for substrate binding, although the nature and specificity of the substrate-binding site is still poorly understood. In the present study, we show that the b ′ domain of human PDI is in conformational exchange, but that its structure is stabilized by the addition of peptide ligands or by binding the x-linker region. The location of the ligand-binding site in b ′ was mapped by NMR chemical shift perturbation and found to consist primarily of residues from the core β-sheet and α-helices 1 and 3. This site is where the x-linker region binds in the X-ray structure of b ′ x and we show that peptide ligands can compete with x binding at this site. The finding that x binds in the principal ligand-binding site of b ′ further supports the hypothesis that x functions to gate access to this site and so modulates PDI activity.
INTRODUCTION
PDI (protein disulfide-isomerase) is a key enzyme responsible for the formation of native disulfide bonds in proteins that enter the secretory pathway of eukaryotic cells. PDI is a multifunctional protein able to catalyse the oxidation and isomerization of disulfide bonds, as well as to bind to unfolded proteins and act as a molecular chaperone [1] . The isomerization of incorrectly paired cysteine residues is often a rate-limiting step on the folding pathway of disulfide bond-containing proteins both in vitro and in vivo [2] [3] [4] . The ability of PDI to combine redox and molecular chaperone-like activities allows it to bind to partly structured folding intermediates and to catalyse simultaneously protein folding and associated native disulfide bond formation [5] . PDI is the archetype of a large family of ER (endoplasmic reticulum)-resident PDI-like proteins [6] .
PDI contains four thioredoxin-like domains, two of which, like thioredoxin itself, have redox-active catalytic sites (a and a ′ )and two of which do not (b and b ′ ). The domain order is a-b-b ′ -xa ′ -c,wherex is a 19-residue linker between the b ′ and a ′ domains [7] and c is a C-terminal acidic tail containing the KDEL (LysAsp-Glu-Leu) ER-retention signal. The a and a ′ domains are responsible for the redox activity of PDI, whereas the b ′ domain has been shown to be essential for ligand binding [8] . The b ′ domain binds both small and large peptide ligands, although large ligands also require the a and a ′ domains to contribute to the overall binding interaction [8, 9] . The b ′ domain is likely to control the substrate specificity of PDI and is known to be required for disulfide isomerization reactions in protein substrates [10] . In ERp57, a PDI family member that is specific for the lectin-like molecular chaperones calnexin and calreticulin, the b ′ domain contains the binding site for these proteins allowing the lectins to recruit nascent glycosylated polypeptides to the isomerase to facilitate folding [11, 12] . PDI has proved to be a difficult protein for three-dimensional structure determination. The first structure for a full-length PDI (yeast Pdi1p) was not published until 2006 [13] , although abundant protein from a variety of sources has been available for many years. This structure was obtained from crystals of yeast Pdi1p grown at 4
• C and revealed a twisted U-shaped molecule where the b and b ′ domains make up the valley floor and the a and a ′ domain are positioned either side with their redox-active catalytic sites facing one another across the central cleft. The U is lined with hydrophobic residues thought to constitute the ligandbinding site. The b ′ domain provides the core of this putative binding site, with the a and a ′ domains contributing hydrophobic residues around their active sites. The b domain extends the hydrophobic site on b ′ and may be important for binding larger molecules. A second crystal form of yeast Ppi1p grown at a higher temperature has shown that the fulllength molecule is conformationally flexible with respect to the orientation and position of the a domain to the rest of the molecule [14] ; such flexibility will tend to prevent regular crystal formation.
Single domain structures for domains a and b of human PDI were determined by NMR more than 10 years ago [15, 16] , and a structure of the isolated a ′ domain has been deposited in the Protein Data Bank (PDB code 1X5C), but there has been no reported NMR structure for the independent b ′ domain of human PDI. However, recently, six three-dimensional structures of mammalian PDI family members containing a b ′ domain have been published (full-length ERp44 [17] , full-length ERp57 in a complex with tapasin [18] , bb ′ domains of ERp57 and ERp72 [12, 19] , and b ′ x and bb ′ domains of human PDI [20, 21] ). In two of these structures, a hydrophobic site similar to that seen in the b ′ domain of yeast has been identified into which another part of the polypeptide chain is bound (the x-linker region in b ′ x [20] and the C-terminal region in ERp44 [17] ). These findings suggest that access to the core ligand-binding site can be gated by a capping structure within the protein, leading to the possibility of high-and low-ligand-affinity states.
To date there are no published structures of PDI with bound peptide ligands or unfolded protein substrates and hence the ligand-binding site has not been identified directly. In the present study, we have used NMR chemical shift perturbation to map the ligand-binding site in the b ′ domain of human PDI and have shown that peptide ligands can compete with the x-linker region for binding at this site. We also show that the neighbouring b domain and x-linker region stabilize the structure of b ′ and that the b domain has an effect on the ligand-binding site, even though this site is distant from the b-b ′ domain-domain interface.
MATERIALS AND METHODS

Recombinant protein expression and purification
Human 3) (buffer A), containing DNase (10 μg/ml) before freezing at − 20
• C. Thawed cell lysate was clarified by centrifugation at 17 400 g for15minandloadedontoacolumn of nickel-chelating Sepharose (GE Healthcare). The column was washed with buffer A containing 25 mM imidazole and 0.5 M NaCl following by buffer A alone, and then the recombinant product eluted with buffer A containing 50 mM EDTA. The eluted protein was dialysed against buffer A or diluted 5× with buffer A before loading on to a Source 30Q ion-exchange column (GE Healthcare). Bound proteins were separated with a linear gradient of 0-500 mM NaCl over 20 column volumes. Fractions were pooled based on SDS/PAGE analysis and concentrated by ultrafiltration (5 kDa cut-off for single domain constructs, 10 kDa cut-off for larger constructs).
b ′ x and bb ′ x constructs were purified further by gel-filtration chromatography. Samples were separated on Superdex 75 or 200 columns (2.6 cm × 55 cm, GE Healthcare) in 20 mM sodium phosphate buffer (pH 7.1) containing 150 mM NaCl. Fractions corresponding to monomer and dimer were well-resolved and were pooled separately.
To prepare triple-labelled ( 2 H, 13 
NMR spectroscopy
NMR samples were typically 0.5-1.5 mM protein in 20 mM sodium phosphate buffer containing 100 or 150 mM NaCl (pH 6.5) and 10 % (v/v) 2 H 2 O in a final volume of 330 μl. Unless stated otherwise, NMR experiments were performed at 600 MHz using a Varian Unity INOVA equipped with a 5 mm HCN z-pulse field gradient probe. All NMR experiments were solvent-suppressed to reduce the water signal using the WATERGATE method [22] , and all indirect NMR dimensions [non-TROSY (transverse relaxation optimized spectroscopy) experiments] were acquired using the hypercomplex method. 15 N/ 1 H-HSQC (heteronuclear single-quantum coherence) spectra were collected at 25 and 40
• C as described by Alanen et al. [23] . Backbone chemical shift assignment for b ′ x (at 25
• C) and bb ′ x (at 40
• C) were carried out using three-dimensional CBCANH and CBCA(CO)NH experiments [24, 25] . Assignments for bb ′ x were also confirmed by analysis of three-dimensional TROSY-HNCA and TROSY-HN(CO)CA experiments acquired at 800 MHz (Varian Unity INOVA) and 25
• C on a deuterated sample prepared as described above. Backbone assignments for b were taken from the BioMagResBank (accession code 4156 [26] ) and the assignments confirmed and mapped on to an 15 N/ 1 H-HSQC spectrum of b collected under the same experimental conditions as the other constructs by analysis of 15 N HSQC-TOCSY and 15 N-HSQC-NOESY spectra. All NMR data were processed using NMRPipe [27] , and spectra were analysed manually using the CCPN Analysis software package [28] .
Peptide ligands
-Somatostatin (AGSKNFFWKTFTSS [8] ) and KFWWFS were generated by peptide synthesis and purified by reverse-phase HPLC. Peptide was added at a 2-fold molar excess over target protein concentration unless stated otherwise.
RESULTS
Expression and purification of b
′ ,b ′ x, bb ′ and bb ′ x PDI domain fragments were purified by a combination of nickelaffinity and anion-exchange chromatography. b ′ x and bb ′ x often gave complex or asymmetric peak profiles during ion-exchange chromatography (Figure 1a) , suggesting the presence of two or more forms, although SDS/PAGE and electrospray ionization-MS analysis on fractions taken across the peak revealed only a single protein species at the correct molecular mass (Figure 1a are found exclusively as dimeric species. Both b ′ x and bb ′ x contain a unique tryptophan residue in the x-linker region of the fragment, and fluorescence analysis of the monomeric and dimeric forms revealed spectra similar to those seen previously for the 'capped' and 'uncapped' forms of b ′ x respectively [20] . We have previously determined the structure of the capped form of b ′ x using X-ray crystallography. This structure shows the xlinker bound in a hydrophobic patch on the surface of b ′ [20] . The monomeric fractions of b ′ x and bb ′ x gave well-resolved NMR spectra, consistent with folded proteins (Figures 2a and 2b ). All the work in the present study was carried out using purified samples of monomeric b ′ x and bb ′ x and dimeric b ′ and bb ′ .
Backbone assignment of b ′ x and bb ′ x
Backbone assignments were obtained from standard tripleresonance datasets acquired at 25
• Cf o rb ′ x and 40
• Cf o r bb ′ x (the elevated temperature for bb ′ x was to compensate for signal reduction from increased NMR relaxation rates owing to the higher molecular mass of this construct). Backbone assignments for bb ′ x were confirmed by analysis of TROSY-HNCA and TROSY-HN(CO)CA experiments using an 81 % non-exchangeable deuterated sample. A series of 15 All spectra were collected at pH 6.5 and 25 • C. b ′ and bb ′ were found to be exclusively dimeric on purification, whereas b ′ x and bb ′ x were found to be both dimeric and monomeric (only spectra for the monomeric form shown here). Some 20 non-overlapping peaks common to b ′ /b ′ x or bb ′ /bb ′ x spectra were used to estimate average F 2 line width at half peak height. The estimates obtained were: Backbone assignment for the x-linker region in both constructs proved to be more challenging than for the rest of the molecule with resonances weak or lacking from the CBCANH and/or CBCA(CO)NH experiments. In b ′ x, two assignment pathways were observed for residues Met 339 -Gln 350 , suggesting at least two structural forms for this region. One pathway consisted of sharp well-resolved peaks; the second pathway consisted of broader peaks more typical in line width to those of the rest of the protein. These two sets of peaks are believed to originate respectively from a (freely mobile) unbound x-linker region and a bound form of x which interacts with a site on the b ′ domain. In contrast, the bb ′ x spectra revealed only one detectable assignment pathway for the x-linker region, although a few unassignable peaks remain in the spectra. The line widths for the peaks in the assigned pathway were narrower compared with the rest of the protein, suggesting that they originate from an unbound form of x.F u r t h e r m o r e , the last five residues (Asp 346 -Gln 350 ) had comparable backbone chemical shifts with unbound x in b ′ x. The signals from an unbound x-linker region are thought to arise from small amounts of uncapped dimer contaminating the samples. Uncapped x gives a characteristic high-field indole amide peak which can be seen in the 15 Figure 2b ). The sharp resonances of the uncapped x-linker region allow it to be detected easily, even when in relatively low amounts.
Effect of peptide ligands on the structure of b
′ and bb
′
The NMR spectra for dimeric b ′ and bb ′ were poor and their broad line widths prevented backbone assignment (Figures 2c  and 2d ). However, in the presence of a peptide ligand (Figures 2e and 2f) , the line shape, resolution and dispersion of these spectra improved markedly, suggesting dissociation of the dimeric form to generate monomers, together with possible ligand-dependent stabilization of the b ′ structure reducing any line-broadening from conformational exchange. The hydrophobic peptide KFWWFS was found to have a significant effect on b ′ (compare Figures 2c and 2e ), giving spectra with line widths comparable with capped b ′ x (Figure 2a ; average line widths given in the legend to Figure 2 ), but this ligand proved to be very difficult to handle reliably owing to its poor solubility. An alternative ligand, -Somatostatin [8] , was used for studies with bb ′ , and this ligand also had a significant effect on the line widths (compare Figures 2d and 2f) , giving values approaching those seen for capped bb ′ x (Figure 2b ). -Somatostatin was also seen to improve the quality of spectra when added to b ′ , but the effect was less marked than when added to bb ′ at the same concentration and significantly poorer than that seen with KFWWFS (results not shown). Experiments were also carried out with the small hydrophobic molecule 2-propylphenol that had been shown previously to interact with the b ′ domain of PDI [29] . This molecule was seen to improve the spectrum of b ′ (results not shown), with average line widths decreasing to 24.4 Hz.
Mapping of the b
′ ligand-binding site
Chemical shift perturbation can be estimated, when comparing spectra where only one of the spectra has been fully assigned, by measuring distances from signals in the assigned spectrum to the nearest peak in the unassigned spectrum. This approach was used to identify the ligand-binding site in b ′ by comparing the assigned 15 N/ 1 H-HSQC spectrum of b ′ x with b ′ + KFWWFS and the assigned spectrum of bb ′ x with bb ′ + -somatostatin. The direct comparison of b ′ with b ′ + KFWWFS or bb ′ with bb ′ + -somatostatin was not possible because of the poor quality of the unliganded spectra (Figures 2c and 2d) . The -somatostatin ligand was also seen to bind to b ′ x as judged by peak shifts in 15 N/ 1 H-HSQC spectra, hence a similar nearest-peak analysis was carried out for b ′ x with b ′ x + -somatostatin. The minimal chemical shift changes seen for the backbone amide resonances of bb ′ generated by comparing spectra for bb ′ x with bb ′ + -somatostatin are shown in Figure 3(a) . The data show that the majority of the chemical shift perturbation maps to the b ′ domain, a finding consistent with the b ′ domain containing the ligand-binding site [7, 8] . In general, the background level of chemical shift change is much higher in b face of α1 that borders the C-terminal end of the binding site. Moderate shifts are also seen at the base of α4 that continues into the x-linker region; chemical shift changes between bb ′ x and bb ′ + -somatostatin in this region may not reflect ligand binding, but may be a direct consequence of x truncation in the bb ′ construct.
Effect of ligand binding on x
The x-linker region contains a unique tryptophan residue (Trp 347 ) and the indole cross-peak from this tryptophan side chain was used previously to detect the difference in environment of the x-linker region between the 'capped' and 'uncapped' forms of the b ′ x domain [20] . Samples of capped b ′ x typically contain a small proportion of uncapped dimeric material and hence two peaks for the tryptophan indole are seen (Figure 2a) . The low-field cross-peak ( 1 H N = 10.39 p.p.m.) is representative of the monomeric capped conformer, and the sharper high-field cross-peak ( 1 H N = 10.12 p.p.m.) representative of the uncapped dimeric form. Interconversion between the two forms is very slow as shown by the presence of two distinct indole peaks in the HSQC spectra. The addition of -somatostatin to samples of (predominantly) monomeric b ′ x was seen to shift the capped indole peak towards that of the uncapped form which remained unchanged in position and appearance (Figure 4) . Furthermore, the degree of shift was dependent on the amount of -somatostatin added to the sample. These results confirm that -somatostatin is able to displace x from the ligand-binding site and that the tryptophan side chain in the capped monomer is in fast exchange between two or more conformational states. Only backbone chemical shifts for the unbound form of x could be assigned for bb ′ x so the perturbation of x may reflect the bound/unbound nature of this region in the two datasets. However, it is unlikely that the assignments for α3 are for the uncapped dimer form as these peaks would be expected to be both broader and significantly weaker than the monomeric capped form, since the uncapped dimer was only present at low levels in the purified sample.
DISCUSSION
The key outcome from the present study is the definition of ligand-binding residues in the b ′ domain of human PDI, and the demonstration that these are precisely the residues that interact with the adjacent x-linker region of PDI in the 'capped' form of the b ′ x construct, supporting the conclusion that the x-linker region gates ligand access to the principal binding site on b ′ [20] . However, this observation was dependent on generating appropriate PDI preparations that gave well-resolved NMR spectra, and this required detailed characterization of several domain combinations and the resolution of multiple forms. Hence the results also provide insights into the dynamics and dimerization behaviour of PDI fragments containing the b ′ domain.
Oligomerization and conformational flexibility of b ′ -containing fragments
Previous work has shown that chemically homogeneous wildtype b ′ x preparations contained more than one species, as judged by intrinsic fluorescence [7, 20] . We have now shown, for both b ′ x and bb ′ x, that two forms can be separated and characterized, a monomeric form that is predominantly in the 'capped' conformation and a dimeric form that is 'uncapped'. In contrast, recombinant b ′ and bb ′ fragments existed exclusively as dimers when purified from E. coli cell lysates.
The line widths observed for the various b ′ domain-containing species analysed here are in the order b
′ x monomer (see the legend to Figure 2 ), although the molecular sizes are in the order bb
The anomalously broad line widths observed for the b ′ dimer suggest that the b ′ domain is in conformational exchange; line broadening is seen throughout the b ′ spectrum (Figure 2c ), suggesting that this dynamic flexibility affects all residues and is not ameliorated by homodimer formation. Interestingly, the bb ′ construct showed narrower line widths than b ′ , even though it is twice the molecular size of b ′ and also forms a homodimer. It therefore appears that the b domain is able to stabilize the b ′ conformation and this stabilization may occur partly through intermolecular interactions within the bb ′ dimer. The second crystal structure for yeast Pdi1p represents a dimeric form of the full-length protein [14] and shows intermolecular interactions between b and b ′ domains that include hydrophobic residues from the ligand-binding site. Similar interactions within the human bb ′ homodimer could stabilize the structure and so account for the narrower line widths seen for bb ′ compared with b ′ . Conversely, our comparison of NMR chemical shifts between the monomeric species b ′ x and bb ′ x (see above) indicates direct effects of the b domain on the adjacent b ′ domain, so intramolecular stabilization effects may also contribute to the differences in line width of b ′ residues between b ′ and bb ′ . It is interesting to note, with regard to the conformational flexibility observed for the b ′ domain, that structural disorder is a common feature of ligand-binding regions of molecular chaperones [30] . The ligand-binding site of PDI has not been identified directly from structure determination of PDI-ligand complexes, but has been inferred from the ligand-binding activity of domain combinations and mutants [7, 8] , and by the identification of hydrophobic surface patches [13] . The site mapped in the present study by chemical shift perturbation on ligand binding is in good agreement with the hydrophobic site identified on the surface of the b ′ domain in the yeast Pdi1p structure ( Figure 6 ). The definition of the site mapped by chemical shift perturbation is broader than that of the hydrophobic surface in Pdi1p, but this reflects the nature of the analysis where the perturbation data highlight changes to the environment of the protein backbone as sensed by the 1 H N and 15 N amide nuclei and not directly by the side chains. It is now clear that the site where peptide ligands bind is also the site where the x-linker interacts in the b ′ x structure [20] . This finding further supports the idea that the x-linker region could act to gate access to the ligand-binding site in human PDI just as the C-terminal region of ERp44 has been shown to cap the ligand-binding site of this PDI family member and compete with exogenous peptide ligands [17] .
-Somatostatin was shown to compete with x for the ligandbinding site on b ′ (Figure 4) . The NMR results suggest that the binding of x is in fast exchange on the NMR timescale as a chemical shift titration producing an averaged peak position is seen for the tryptophan indole resonance upon addition of ligand. The competing ligand changes the proportion of bound and unbound forms of x and so shifts the averaged peak position. The indole peak in different peptide ligand concentrations is seen to shift in a line between the unbound conformation (assumed to have the same 15 Na n d 1 H N resonances as the uncapped contaminant) and the maximally capped form seen when no competing ligand is present. The proposed fast-exchange properties of the tryptophan indole peak are consistent with our finding that this resonance is virtually devoid of NOEs (nuclear Overhauser effects) to other residues in the protein in a 15 N-edited NOESY experiment. Exchange of x between two or more forms would broaden any NOESY signals and so make them difficult to detect. From the data presented in Figure 4 , the dissociation constant for the b ′ x--somatostatin complex is in the range 0.1-1.0 mM. This affinity is similar to that of mastoparan (0.13 mM), and slightly weaker than the related peptide somatostatin (0.035 mM), binding to a fragment of PDI containing b and b ′ domains ( [21] ; and further description of the construct below). Sites elsewhere in the fulllength protein, such as those identified around the redox-active sites in the a and a ′ domains [13] , will contribute significantly to the overall binding affinity of PDI to larger unfolded protein substrates.
Comparison with data from an alternative construct
Purification and NMR structural data have recently been published for a construct of human PDI that is intermediate in length between the bb ′ and bb ′ x constructs described in the present study. The protein investigated by Denisov et al. [21] comprises the bb ′ domains and extends for an additional eight residues at the Cterminus compared with the bb ′ fragment in the present study, thus including approximately half of the x-linker region [21] . This construct (extended bb ′ or truncated bb ′ x?) was isolated as monomeric and dimeric species that could be separated by gel-filtration chromatography; therefore the first eight residues of x are sufficient for the stable formation of the monomeric form. Interestingly, the first eight residues of x include a β-strand known to make antiparallel interactions with the core β-sheet of the b ′ domain [20] ; however, this strand is not evident in the NMR structure determined for the extended bb ′ construct [21] . It is likely that this strand forms only transiently, or not at all, without the additional stabilizing interactions made by the second half of the x-linker region [20] .
The monomeric form of the extended bb ′ construct gave NMR spectra of similar resolution to those found by us for bb ′ x,a s judged by simple comparison of 15 N/ 1 H-HSQC data (Figure 2b and [31] ). Comparison of the published backbone assignments for the extended bb ′ fragment [31] with our data for bb ′ x showed a close agreement except for the regions known to be involved in the interaction with x in the capped conformer ( Figure 7 ). This is to be expected, as the bb ′ fragment does not possess the second half of the x-linker region that interacts with the hydrophobic ligand-binding site; hence a comparison is being made between structures where x is bound and unbound. The regions that show the greatest difference are Arg 283 -Phe 287 , Met 307 -Tyr 310 and Glu 316 . These regions map to α3 which interacts with x in the ligandbinding site and the β-strand (Met 307 -Lys 311 ) which forms an antiparallel interaction with the first half of x in bb ′ x, but not in bb ′ (see the previous paragraph). The backbone assignments for the extended bb ′ construct show two separate pathways from Lys 333 , the start of the x-linker region [31] . This finding is consistent with our findings for b ′ x and bb ′ x and suggests that the shortened x-linker region of this construct exists in more than one conformation, as we have observed for b ′ x and bb ′ x. Denisov et al. [21] have also mapped the ligand-binding site on their extended bb ′ construct of human PDI using chemical shift perturbation and employing -somatostatin, mastoparan and 'scrambled' RNase as ligands. The site defined in their work is very similar to ours (see Figure 6 for a direct comparison). The The example given here is for the b ′ x construct. The peptide ligand (black) is able to displace the x-linker region (white) from the hydrophobic binding site (grey). Uncontrolled exposure of the binding site is likely to result in homodimerization; a conformation seen for all the b ′ -containing constructs of the present study. The binding of x to the hydrophobic binding site prevents dimer formation and hence the in vitro rate of conversion of capped monomer into uncapped dimer was found to be very low. An 'uncapped monomer' state is presumed to exist as a transient intermediate between the monomer states depicted (capped, ligand-bound) and the uncapped dimer, but it is not shown since we have no evidence that it exists in detectable quantities under the conditions we have studied. most significant difference between the datasets is that Denisov et al. [21] observed chemical shift changes in α3 which runs along the top of the ligand-binding site as shown in Figure 5 (d), whereas we saw very few shifts in this region (with the exception of Asn 281 and Leu 285 ). The lack of perturbation in the present study suggests that there is limited environmental change sensed by the protein backbone in this region when x is displaced by a peptide ligand (as in the present study) compared with when a ligand is bound directly by a 'naked' domain where the x-linker region is truncated.
Control of access to the binding site on the b
′ domain of PDI Chaperones and folding catalysts face an issue concerning how to control exposure of the hydrophobic sites by which they interact with their substrates. If such a site is fully exposed, then there is a clear risk of uncontrolled binding, and the possibility of dimerization and even aggregation. One strategy to avoid these problems might be for such a site to be capped or otherwise concealed in the absence of substrate. We do not have sufficient structural information on a range of chaperones in the presence and absence of their substrates to test this or to analyse the various structural strategies by which it might be achieved. However, in the case of PDI and ERp44, it does appear that the primary ligand-binding site on the b ′ domain is masked or 'capped' by interaction with an adjacent mobile region. Binding of substrate will then displace the 'cap' providing conditional access to the binding site, which is never fully exposed. A cartoon depicting the displacement of x by a peptide ligand from the substrate binding site on b ′ x is shown in Figure 8 . This model for PDI and ERp44 is similar to that proposed for the Hsp70 (heatshock protein 70) family chaperones [32] , where a hydrophobic sequence that links the NBD (nucleotide-binding domain) to the SBD (substrate-binding domain) has been observed in two alternative conformations: an 'out' conformation in which the linker is exposed to solvent, and an 'in' conformation in which the linker is packed on to a hydrophobic patch on the SBD. In this case, binding of ATP to the NBD is thought to act allosterically to shift the balance between these two alternative conformations of the interdomain linker and hence control the binding of ligands to the SBD.
At this point, it is difficult to predict whether this strategy of ligand displacement of a local 'cap' on the primary noncovalent ligand-binding site will be a general theme among members of the PDI family, as the current structural data on complexes with ligands are sparse. There is a recent structure of the ERp57-tapasin complex [18] and convincing models exist for ERp57 interactions within the MHC peptide-loading complex [18, 33] , and when bound to calnexin and a monoglucosylated protein folding intermediate [12, 34] . However, the role of ERp57 in these complexes is rather different from that of PDI which we interpret as operating by using direct non-covalent binding interactions with the substrate (mainly involving b ′ ) to destabilize the conformation of partially folded species while simultaneously catalysing disulfide interchange in the substrate through covalent interactions with the active sites in the a and a ′ domains. The work in the present study shows that b ′ is a conformationally active domain that forms homodimers unless peptide ligands or the x-linker region are bound at its hydrophobic ligandbinding site. Ligand and x binding dissociate the dimer form and stabilize the tertiary structure. The binding of x is competitive with ligands and in fast exchange between two or more states. Controlled exposure of the hydrophobic binding site and the conformational properties of b ′ are likely to be key to the function of PDI. The x-linker region provides a mechanism for controlling access to the hydrophobic binding site and its displacement by substrate could initiate rearrangement of the domain architecture of PDI triggering changes in the protein folding activity by coupling the non-covalent substrate interactions at the b ′ domain with covalent substrate interactions with the redox-active sites on the a and a ′ domains. What is now required is to define better by both direct and indirect approaches, how ligand binding affects the relative orientations and dynamics of the various domains and sites within PDI.
